Bagneux, France, March 3, 2014 (GLOBE NEWSWIRE) -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, today announced that Dr. Pierre-Henri Benhamou, Chairman & CEO and Mr. David Schilansky, Chief Financial Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 11th in Miami, Florida.
Help employers find you! Check out all the jobs and post your resume.
